Enzolytics (PK) Stock Price

-0.0141 (-7.01%)


52 Week Range


Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Enzolytics Inc (PK) ENZC OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0141 -7.01% 0.1869 16:59:04
Open Price Low Price High Price Close Price Prev Close
0.198 0.1855 0.207 0.1869 0.201
Bid Price Ask Price Spread News
0.186 0.1942 0.0082 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,195 18,509,342 $ 0.190587 $ 3,527,647 - 0.0002 - 0.958
Last Trade Time Type Quantity Stock Price Currency
16:01:39 formt 29,500 $ 0.186 USD

Enzolytics (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 522.93M 2.80B 1.88B $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
6.10M $ - - - -

more financials information »

Enzolytics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ENZC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.270.31950.18210.237103137,359,223-0.0831-30.78%
1 Month0.120.31950.11110.221994244,033,3610.066955.75%
3 Months0.22020.31950.08660.175464442,427,902-0.0333-15.12%
6 Months0.06410.9580.03750.252650242,218,7890.1228191.58%
1 Year0.00040.9580.00020.080884775,939,9820.186546,625.0%
3 Years0.005890.9580.00010.064614244,665,2220.181013,073.17%
5 Years0.00450.9580.00010.064518632,792,9150.18244,053.33%

Enzolytics (PK) Description

Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The Company is committed to creating drugs for the better health of mankind. ENZC's flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from major neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210619 05:16:12